Exploring molecular genetics of bladder cancer: lessons learned from mouse models
Open Access
- 1 January 2012
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 5 (3), 323-332
- https://doi.org/10.1242/dmm.008888
Abstract
Summary: Urothelial cell carcinoma (UCC) of the bladder is one of the most common malignancies worldwide, causing considerable morbidity and mortality. It is unusual among the epithelial carcinomas because tumorigenesis can occur by two distinct pathways: low-grade, recurring papillary tumours usually contain oncogenic mutations in FGFR3 or HRAS, whereas high-grade, muscle-invasive tumours with metastatic potential generally have defects in the pathways controlled by the tumour suppressors p53 and retinoblastoma (RB). Over the past 20 years, a plethora of genetically engineered mouse (GEM) models of UCC have been developed, containing deletions or mutations of key tumour suppressor genes or oncogenes. In this review, we provide an up-to-date summary of these GEM models, analyse their flaws and weaknesses, discuss how they have advanced our understanding of UCC at the molecular level, and comment on their translational potential. We also highlight recent studies supporting a role for dysregulated Wnt signalling in UCC and the development of mouse models that recapitulate this dysregulation.Keywords
This publication has 103 references indexed in Scilit:
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- Loss of p53 and Acquisition of Angiogenic MicroRNA Profile Are Insufficient to Facilitate Progression of Bladder Urothelial Carcinoma in Situ to Invasive CarcinomaPublished by Elsevier BV ,2011
- Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesisCell Death & Disease, 2011
- β-Catenin activation synergizes with PTEN loss to cause bladder cancer formationOncogene, 2010
- In vivo micro-CT imaging of liver lesions in small animal modelsMethods, 2010
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002
- Intestinal polyposis in mice with a dominant stable mutation of the beta -catenin geneThe EMBO Journal, 1999